BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) is pleased to announce that on May 1, 2023, staff of the Ontario Securities Commission (the “OSC”) granted a full revocation of the failure-to-file cease trade order (“FFCTO”) that was previously issued against the Company on August 26, 2022. The Company had been subject to the FFCTO for failure to meet the deadlines to file the Company’s audited annual financial statements for the year ende
Source link
